Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy
Loren K. Mell(University of California San Diego), Arno J. Mundt(University of California San Diego), Jean Hurteau(University of Illinois Chicago), Ernst Lengyel(University of Illinois Chicago), John C. Roeske(Loyola University Chicago), J.D. Kochanski(University of Illinois Chicago), Neil Mehta(University of Chicago), Josh J. Haslam(University of Chicago), Yvonne Collins(University of Illinois Chicago), S. Diane Yamada(University of Chicago)
International Journal of Radiation Oncology*Biology*Physics
June 15, 2006
Cited by 331
Related Papers
Ovarian Cancer Development and Metastasis
|American Journal Of Pathology|2010|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632